{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T23:12:40Z","timestamp":1793833960357,"version":"4.6.1"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,8,3]],"date-time":"2017-08-03T00:00:00Z","timestamp":1501718400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["R01 HL73101-01A and R01 HL107910-01"],"award-info":[{"award-number":["R01 HL73101-01A and R01 HL107910-01"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetologia"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1007\/s00125-017-4390-4","type":"journal-article","created":{"date-parts":[[2017,8,3]],"date-time":"2017-08-03T02:33:48Z","timestamp":1501727628000},"page":"21-28","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":775,"title":["Diabetic cardiomyopathy: a hyperglycaemia- and insulin-resistance-induced heart disease"],"prefix":"10.1007","volume":"61","author":[{"given":"Guanghong","family":"Jia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Whaley-Connell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James R.","family":"Sowers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,8,3]]},"reference":[{"key":"4390_CR1","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/0002-9149(72)90595-4","volume":"30","author":"S Rubler","year":"1972","unstructured":"Rubler S, Dlugash J, Yuceoglu YZ, Kumral T, Branwood AW, Grishman A (1972) New type of cardiomyopathy associated with diabetic glomerulosclerosis. Am J Cardiol 30:595\u2013602","journal-title":"Am J Cardiol"},{"key":"4390_CR2","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0002-9149(74)90089-7","volume":"34","author":"WB Kannel","year":"1974","unstructured":"Kannel WB, Hjortland M, Castelli WP (1974) Role of diabetes in congestive heart failure: the Framingham study. Am J Cardiol 34:29\u201334","journal-title":"Am J Cardiol"},{"key":"4390_CR3","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1172\/JCI108843","volume":"60","author":"TJ Regan","year":"1977","unstructured":"Regan TJ, Lyons MM, Ahmed SS et al (1977) Evidence for cardiomyopathy in familial diabetes mellitus. J Clin Invest 60:884\u2013899","journal-title":"J Clin Invest"},{"key":"4390_CR4","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/nrendo.2015.216","volume":"12","author":"G Jia","year":"2016","unstructured":"Jia G, DeMarco VG, Sowers JR (2016) Insulin resistance and hyperinsulinaemia in diabetic cardiomyopathy. Nat Rev Endocrinol 12:144\u2013153","journal-title":"Nat Rev Endocrinol"},{"key":"4390_CR5","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1161\/HYPERTENSIONAHA.115.06015","volume":"66","author":"G Jia","year":"2015","unstructured":"Jia G, Habibi J, DeMarco VG et al (2015) Endothelial mineralocorticoid receptor deletion prevents diet-induced cardiac diastolic dysfunction in females. Hypertension 66:1159\u20131167","journal-title":"Hypertension"},{"key":"4390_CR6","doi-asserted-by":"crossref","first-page":"633","DOI":"10.2337\/diacare.17.7.633","volume":"17","author":"DC Raev","year":"1994","unstructured":"Raev DC (1994) Which left ventricular function is impaired earlier in the evolution of diabetic cardiomyopathy? An echocardiographic study of young type I diabetic patients. Diabetes Care 17:633\u2013639","journal-title":"Diabetes Care"},{"key":"4390_CR7","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/S0140-6736(11)60471-6","volume":"378","author":"M Lind","year":"2011","unstructured":"Lind M, Bounias I, Olsson M, Gudbjornsdottir S, Svensson AM, Rosengren A (2011) Glycaemic control and incidence of heart failure in 20,985 patients with type 1 diabetes: an observational study. Lancet 378:140\u2013146","journal-title":"Lancet"},{"key":"4390_CR8","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/s12872-016-0288-1","volume":"16","author":"L Brunvand","year":"2016","unstructured":"Brunvand L, Fugelseth D, Stensaeth KH, Dahl-Jorgensen K, Margeirsdottir HD (2016) Early reduced myocardial diastolic function in children and adolescents with type 1 diabetes mellitus a population-based study. BMC Cardiovasc Disord 16:103","journal-title":"BMC Cardiovasc Disord"},{"key":"4390_CR9","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s12872-016-0242-2","volume":"16","author":"D Suran","year":"2016","unstructured":"Suran D, Sinkovic A, Naji F (2016) Tissue Doppler imaging is a sensitive echocardiographic technique to detect subclinical systolic and diastolic dysfunction of both ventricles in type 1 diabetes mellitus. BMC Cardiovasc Disord 16:72","journal-title":"BMC Cardiovasc Disord"},{"key":"4390_CR10","doi-asserted-by":"crossref","first-page":"H125","DOI":"10.1152\/ajpheart.00165.2009","volume":"297","author":"T Radovits","year":"2009","unstructured":"Radovits T, Korkmaz S, Loganathan S et al (2009) Comparative investigation of the left ventricular pressure-volume relationship in rat models of type 1 and type 2 diabetes mellitus. Am J Physiol Heart Circ Physiol 297:H125\u2013H133","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"4390_CR11","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.2337\/diacare.27.8.1879","volume":"27","author":"GA Nichols","year":"2004","unstructured":"Nichols GA, Gullion CM, Koro CE, Ephross SA, Brown JB (2004) The incidence of congestive heart failure in type 2 diabetes: an update. Diabetes Care 27:1879\u20131884","journal-title":"Diabetes Care"},{"key":"4390_CR12","doi-asserted-by":"crossref","first-page":"2668","DOI":"10.1161\/01.CIR.103.22.2668","volume":"103","author":"C Iribarren","year":"2001","unstructured":"Iribarren C, Karter AJ, Go AS et al (2001) Glycemic control and heart failure among adult patients with diabetes. Circulation 103:2668\u20132673","journal-title":"Circulation"},{"key":"4390_CR13","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1136\/bmj.321.7258.405","volume":"321","author":"IM Stratton","year":"2000","unstructured":"Stratton IM, Adler AI, Neil HA et al (2000) Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 321:405\u2013412","journal-title":"BMJ"},{"key":"4390_CR14","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s10741-013-9388-5","volume":"19","author":"E Adeghate","year":"2014","unstructured":"Adeghate E, Singh J (2014) Structural changes in the myocardium during diabetes-induced cardiomyopathy. Heart Fail Rev 19:15\u201323","journal-title":"Heart Fail Rev"},{"key":"4390_CR15","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1210\/er.2003-0012","volume":"25","author":"ZY Fang","year":"2004","unstructured":"Fang ZY, Prins JB, Marwick TH (2004) Diabetic cardiomyopathy: evidence, mechanisms, and therapeutic implications. Endocr Rev 25:543\u2013567","journal-title":"Endocr Rev"},{"key":"4390_CR16","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.jdiacomp.2007.12.005","volume":"23","author":"DZ Mytas","year":"2009","unstructured":"Mytas DZ, Stougiannos PN, Zairis MN, Foussas SG, Pyrgakis VN, Kyriazis IA (2009) Diabetic myocardial disease: pathophysiology, early diagnosis and therapeutic options. J Diabetes Complicat 23:273\u2013282","journal-title":"J Diabetes Complicat"},{"key":"4390_CR17","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1900\/RDS.2006.3.108","volume":"3","author":"J Wang","year":"2006","unstructured":"Wang J, Song Y, Wang Q, Kralik PM, Epstein PN (2006) Causes and characteristics of diabetic cardiomyopathy. Rev Diabet Stud 3:108\u2013117","journal-title":"Rev Diabet Stud"},{"key":"4390_CR18","doi-asserted-by":"crossref","first-page":"E201","DOI":"10.1152\/ajpendo.00497.2011","volume":"302","author":"JA Kim","year":"2012","unstructured":"Kim JA, Jang HJ, Martinez-Lemus LA, Sowers JR (2012) Activation of mTOR\/p70S6 kinase by ANG II inhibits insulin-stimulated endothelial nitric oxide synthase and vasodilation. Am J Physiol Endocrinol Metab 302:E201\u2013E208","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"4390_CR19","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1161\/CIRCULATIONAHA.107.728550","volume":"117","author":"L Heerebeek van","year":"2008","unstructured":"van Heerebeek L, Hamdani N, Handoko ML et al (2008) Diastolic stiffness of the failing diabetic heart: importance of fibrosis, advanced glycation end products, and myocyte resting tension. Circulation 117:43\u201351","journal-title":"Circulation"},{"key":"4390_CR20","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.ahj.2015.08.008","volume":"170","author":"M Lazo","year":"2015","unstructured":"Lazo M, Halushka MK, Shen L et al (2015) Soluble receptor for advanced glycation end products and the risk for incident heart failure: the atherosclerosis risk in communities study. Am Heart J 170:961\u2013967","journal-title":"Am Heart J"},{"key":"4390_CR21","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1111\/j.1582-4934.2008.00547.x","volume":"13","author":"H Ma","year":"2009","unstructured":"Ma H, Li SY, Xu P et al (2009) Advanced glycation endproduct (AGE) accumulation and AGE receptor (RAGE) up-regulation contribute to the onset of diabetic cardiomyopathy. J Cell Mol Med 13:1751\u20131764","journal-title":"J Cell Mol Med"},{"key":"4390_CR22","doi-asserted-by":"crossref","first-page":"C593","DOI":"10.1152\/ajpcell.00069.2015","volume":"309","author":"A Makino","year":"2015","unstructured":"Makino A, Dai A, Han Y et al (2015) O-GlcNAcase overexpression reverses coronary endothelial cell dysfunction in type 1 diabetic mice. Am J Physiol Cell Physiol 309:C593\u2013C599","journal-title":"Am J Physiol Cell Physiol"},{"key":"4390_CR23","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1161\/01.RES.0000165478.06813.58","volume":"96","author":"Y Hu","year":"2005","unstructured":"Hu Y, Belke D, Suarez J et al (2005) Adenovirus-mediated overexpression of O-GlcNAcase improves contractile function in the diabetic heart. Circ Res 96:1006\u20131013","journal-title":"Circ Res"},{"key":"4390_CR24","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s12929-016-0309-5","volume":"24","author":"TW Lee","year":"2017","unstructured":"Lee TW, Bai KJ, Lee TI, Chao TF, Kao YH, Chen YJ (2017) PPARs modulate cardiac metabolism and mitochondrial function in diabetes. J Biomed Sci 24:5","journal-title":"J Biomed Sci"},{"key":"4390_CR25","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1172\/JCI0214080","volume":"109","author":"BN Finck","year":"2002","unstructured":"Finck BN, Lehman JJ, Leone TC et al (2002) The cardiac phenotype induced by PPAR\u03b1 overexpression mimics that caused by diabetes mellitus. J Clin Invest 109:121\u2013130","journal-title":"J Clin Invest"},{"key":"4390_CR26","doi-asserted-by":"crossref","first-page":"E923","DOI":"10.1152\/ajpendo.00360.2002","volume":"284","author":"LL Atkinson","year":"2003","unstructured":"Atkinson LL, Kozak R, Kelly SE, Onay Besikci A, Russell JC, Lopaschuk GD (2003) Potential mechanisms and consequences of cardiac triacylglycerol accumulation in insulin-resistant rats. Am J Physiol Endocrinol Metab 284:E923\u2013E930","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"4390_CR27","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.2337\/dc16-0542","volume":"39","author":"S Mudaliar","year":"2016","unstructured":"Mudaliar S, Alloju S, Henry RR (2016) Can a shift in fuel energetics explain the beneficial cardiorenal outcomes in the EMPA-REG OUTCOME study? A unifying hypothesis. Diabetes Care 39:1115\u20131122","journal-title":"Diabetes Care"},{"key":"4390_CR28","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1186\/1475-2840-12-158","volume":"12","author":"ZW Liu","year":"2013","unstructured":"Liu ZW, Zhu HT, Chen KL et al (2013) Protein kinase RNA-like endoplasmic reticulum kinase (PERK) signaling pathway plays a major role in reactive oxygen species (ROS)-mediated endoplasmic reticulum stress-induced apoptosis in diabetic cardiomyopathy. Cardiovasc Diabetol 12:158","journal-title":"Cardiovasc Diabetol"},{"key":"4390_CR29","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1152\/physrev.00015.2006","volume":"86","author":"SJ Marciniak","year":"2006","unstructured":"Marciniak SJ, Ron D (2006) Endoplasmic reticulum stress signaling in disease. Physiol Rev 86:1133\u20131149","journal-title":"Physiol Rev"},{"key":"4390_CR30","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1101\/sqb.2011.76.010777","volume":"76","author":"CH Yi","year":"2011","unstructured":"Yi CH, Vakifahmetoglu-Norberg H, Yuan J (2011) Integration of apoptosis and metabolism. Cold Spring Harb Symp Quant Biol 76:375\u2013387","journal-title":"Cold Spring Harb Symp Quant Biol"},{"key":"4390_CR31","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.2337\/db10-0351","volume":"60","author":"Z Xie","year":"2011","unstructured":"Xie Z, Lau K, Eby B et al (2011) Improvement of cardiac functions by chronic metformin treatment is associated with enhanced cardiac autophagy in diabetic OVE26 mice. Diabetes 60:1770\u20131778","journal-title":"Diabetes"},{"key":"4390_CR32","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1042\/cs0900189","volume":"90","author":"JA Miller","year":"1996","unstructured":"Miller JA, Floras JS, Zinman B, Skorecki KL, Logan AG (1996) Effect of hyperglycaemia on arterial pressure, plasma renin activity and renal function in early diabetes. Clin Sci (Lond) 90:189\u2013195","journal-title":"Clin Sci (Lond)"},{"key":"4390_CR33","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1681\/ASN.V1081778","volume":"10","author":"JA Miller","year":"1999","unstructured":"Miller JA (1999) Impact of hyperglycemia on the renin angiotensin system in early human type 1 diabetes mellitus. J Am Soc Nephrol 10:1778\u20131785","journal-title":"J Am Soc Nephrol"},{"key":"4390_CR34","doi-asserted-by":"crossref","first-page":"5692","DOI":"10.1210\/en.2012-1780","volume":"153","author":"JZ Shen","year":"2012","unstructured":"Shen JZ, Young MJ (2012) Corticosteroids, heart failure, and hypertension: a role for immune cells? Endocrinology 153:5692\u20135700","journal-title":"Endocrinology"},{"key":"4390_CR35","doi-asserted-by":"crossref","first-page":"e104771","DOI":"10.1371\/journal.pone.0104771","volume":"9","author":"B Luo","year":"2014","unstructured":"Luo B, Li B, Wang W et al (2014) NLRP3 gene silencing ameliorates diabetic cardiomyopathy in a type 2 diabetes rat model. PLoS One 9:e104771","journal-title":"PLoS One"},{"key":"4390_CR36","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jacc.2013.02.092","volume":"62","author":"WJ Paulus","year":"2013","unstructured":"Paulus WJ, Tschope C (2013) A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation. J Am Coll Cardiol 62:263\u2013271","journal-title":"J Am Coll Cardiol"},{"key":"4390_CR37","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.jchf.2015.10.007","volume":"4","author":"C Franssen","year":"2016","unstructured":"Franssen C, Chen S, Unger A et al (2016) Myocardial microvascular inflammatory endothelial activation in heart failure with preserved ejection fraction. JACC Heart Fail 4:312\u2013324","journal-title":"JACC Heart Fail"},{"key":"4390_CR38","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.2337\/diabetes.53.6.1418","volume":"53","author":"MA Vincent","year":"2004","unstructured":"Vincent MA, Clerk LH, Lindner JR et al (2004) Microvascular recruitment is an early insulin effect that regulates skeletal muscle glucose uptake in vivo. Diabetes 53:1418\u20131423","journal-title":"Diabetes"},{"key":"4390_CR39","doi-asserted-by":"crossref","first-page":"125","DOI":"10.3389\/fphys.2016.00125","volume":"7","author":"F Westermeier","year":"2016","unstructured":"Westermeier F, Riquelme JA, Pavez M et al (2016) New molecular insights of insulin in diabetic cardiomyopathy. Front Physiol 7:125","journal-title":"Front Physiol"},{"key":"4390_CR40","doi-asserted-by":"crossref","first-page":"18396","DOI":"10.3402\/jev.v1i0.18396","volume":"1","author":"OG Jong de","year":"2012","unstructured":"de Jong OG, Verhaar MC, Chen Y et al (2012) Cellular stress conditions are reflected in the protein and RNA content of endothelial cell-derived exosomes. J Extracell Vesicles 1:18396","journal-title":"J Extracell Vesicles"},{"key":"4390_CR41","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/cvr\/cvv260","volume":"109","author":"NA Garcia","year":"2016","unstructured":"Garcia NA, Moncayo-Arlandi J, Sepulveda P, Diez-Juan A (2016) Cardiomyocyte exosomes regulate glycolytic flux in endothelium by direct transfer of GLUT transporters and glycolytic enzymes. Cardiovasc Res 109:397\u2013408","journal-title":"Cardiovasc Res"},{"key":"4390_CR42","doi-asserted-by":"crossref","first-page":"3111","DOI":"10.2337\/db15-1563","volume":"65","author":"X Wang","year":"2016","unstructured":"Wang X, Gu H, Huang W et al (2016) Hsp20-mediated activation of exosome biogenesis in cardiomyocytes improves cardiac function and angiogenesis in diabetic mice. Diabetes 65:3111\u20133128","journal-title":"Diabetes"},{"key":"4390_CR43","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.cardfail.2006.08.211","volume":"12","author":"GG Sokos","year":"2006","unstructured":"Sokos GG, Nikolaidis LA, Mankad S, Elahi D, Shannon RP (2006) Glucagon-like peptide-1 infusion improves left ventricular ejection fraction and functional status in patients with chronic heart failure. J Card Fail 12:694\u2013699","journal-title":"J Card Fail"},{"key":"4390_CR44","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/S2213-8587(15)00044-3","volume":"3","author":"JA Udell","year":"2015","unstructured":"Udell JA, Cavender MA, Bhatt DL, Chatterjee S, Farkouh ME, Scirica BM (2015) Glucose-lowering drugs or strategies and cardiovascular outcomes in patients with or at risk for type 2 diabetes: a meta-analysis of randomised controlled trials. Lancet Diabetes Endocrinol 3:356\u2013366","journal-title":"Lancet Diabetes Endocrinol"},{"key":"4390_CR45","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1056\/NEJMoa1504720","volume":"373","author":"B Zinman","year":"2015","unstructured":"Zinman B, Wanner C, Lachin JM et al (2015) Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes. N Engl J Med 373:2117\u20132128","journal-title":"N Engl J Med"},{"key":"4390_CR46","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1161\/CIRCULATIONAHA.108.777326","volume":"118","author":"BP Shapiro","year":"2008","unstructured":"Shapiro BP, Owan TE, Mohammed SF et al (2008) Advanced glycation end products accumulate in vascular smooth muscle and modify vascular but not ventricular properties in elderly hypertensive canines. Circulation 118:1002\u20131010","journal-title":"Circulation"},{"key":"4390_CR47","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1093\/eurjhf\/hfr067","volume":"13","author":"JW Hartog","year":"2011","unstructured":"Hartog JW, Willemsen S, van Veldhuisen DJ et al (2011) Effects of alagebrium, an advanced glycation endproduct breaker, on exercise tolerance and cardiac function in patients with chronic heart failure. Eur J Heart Fail 13:899\u2013908","journal-title":"Eur J Heart Fail"}],"container-title":["Diabetologia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00125-017-4390-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-017-4390-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-017-4390-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,31]],"date-time":"2022-07-31T15:19:43Z","timestamp":1659280783000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00125-017-4390-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,3]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["4390"],"URL":"https:\/\/doi.org\/10.1007\/s00125-017-4390-4","relation":{},"ISSN":["0012-186X","1432-0428"],"issn-type":[{"value":"0012-186X","type":"print"},{"value":"1432-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,3]]}}}